Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/f110cd9d-e4b3-49c0-a6a6-5f31c4f6a1c1/

ECS

ECS Botanics Holdings Ltd
Chart
0.01 AUD
Latest Week 2026-07-24
Snapshot 2026-07-26 · 0.7w · Fresh
0.61
OS Score
57.0%
Value
55.0%
Quality
57.0%
Momentum
5/9
F-Score
0.560
QV
Strategy Eligibility
2 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
44.2%
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
Rev +30%
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
57.0%ile
P/E
4.8×
P/S
0.5×
P/B
0.3×
E/P
0.2326
FCF Yield
-0.519
EBITDA/EV
0.442
SH Yield
-0.396
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
43.00000000
/100 — 1=cheapest
VC2 (Trending Value)
43.00000000
/100
VC3 (Buyback)
43.00000000
/100
P/E of 4.8x places this firmly in deep value territory. Negative FCF yield (-51.9%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
55.0%ile
ROE
0.071
ROA
0.061
Net Margin
0.099
Op Margin
0.087
GPA
0.278
Current
4.58
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.302
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
57.0%ile
6M Return
-14.3%
12M Return
-33.3%
12-1 Mom
-55.6%
Risk-Adj
-0.69
Vol 252d
80.5%
Vol 60d
190.9%
↑ Expanding
Max DD 12M
-52.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -56% signals a downtrend — price is moving against you. Near-term vol (191%) is expanding vs long-term (80%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.61
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 145 peers
Sector Value %ile
65.8%
Sector Quality %ile
62.3%
P/E z-score
-0.50
P/B z-score
-0.58
Sector Avg OS
42.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 97.0% 89.0%
SDI SDI Limited 96.0% 86.0% 88.0% 96.0%
BP8 BPH Global Ltd 93.0% 81.0% 80.0% 81.0%
AGN Argenica Therapeutics Limited 93.0% 82.0% 80.0% 81.0%
PCK PainChek Limited 89.0% 78.0% 76.0% 77.0%
TRI TrivarX Limited 87.0% 76.0% 75.0% 76.0%
ACW Actinogen Medical Limited 85.0% 74.0% 73.0% 74.0%
ACR Acrux Limited 85.0% 74.0% 73.0% 74.0%
Factor Interactions
Growth at Reasonable Price
Revenue growing 30% with P/E of 5×. Growth isn't fully priced in.
Volatility Expanding
60-day vol (191%) significantly exceeds 252-day (80%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
71.3% avg (7 factors)
Quality
C
49.2% avg (6 factors)
Momentum
F
6.8% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.610—0
Value %ile0.570—0
Quality %ile0.550—0
Momentum %ile0.570—0
F-Score5.000—0
Confidence0.236—8
Volatility0.805—8
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
4.83
Earnings Yield (E/P)
0.2326
Price / Sales
0.48
Price / Book
0.34
FCF Yield
-51.9%
EBITDA / EV
44.2%
Sales Yield (1/P·S)
2.6805
Shareholder Yield
Div + net buyback / mktcap
-39.6%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
7.1%
Return on Assets
6.1%
Net Margin
9.9%
Operating Margin
8.7%
Gross Profit / Assets
Novy-Marx GPA
27.8%
Current Ratio
4.58
MomentumPrice trend strength over different horizons
6M Return
-14.3%
12M Return
-33.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-55.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.69
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
30.2%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Buyback Yield
-39.6%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
43
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
43
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
43
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity